Results 1 to 10 of about 38,527 (248)

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans : lost in translation [PDF]

, 2013
We greatly appreciate the comments offered by Drs Rolle, Takematsu, and Hoffman and the opportunity to put our work into a wider perspective. We share the view that our work does not reflect the clinical situation but rather provides a proof of mechanism
Boehrer, Brunt, Dafters, Docherty, Grunau, Henry, Hysek, Hysek, Hysek, Hysek, Hysek, Liechti, Liechti, Martin, Mills, Mithoefer, Morefield, Oehen, Parrott, Ramoska, Rietjens, Rogers, Rusyniak, Schutte, Sprague, Sprague, Williams   +26 more
core   +3 more sources

S‐ and R‐Carvedilol Prevent Benzo(a)pyrene‐Induced Lung Carcinogenesis [PDF]

Thoracic Cancer
Lung cancer is the most common and deadly type of cancer. Our previous study showed that carvedilol, a β‐blocker, can prevent lung cancer induced by benzo(a)pyrene [B(a)P].
Ayaz Shahid, Steven Yeung, Bradley T. Andresen, Ying Huang   +3 more
doaj   +2 more sources

Carvedilol [PDF]

Reactions Weekly, 2020
Geysa Couto Ribeiro von Kriiger, Jéssica Luciano da Costa, Jean Vinicius Cardoso dos Santos Ocampo, Maria Inez Montagner, Cinthia Gabriel Meireles, Patrícia Medeiros de Souza   +5 more
  +7 more sources

Post-carvedilol myocardial function in cats with obstructive hypertrophic cardiomyopathy [PDF]

Frontiers in Veterinary Science
IntroductionHypertrophic cardiomyopathy (HCM) is the most prevalent cardiac disease in cats, and one phenotype includes obstructive HCM with dynamic left ventricular outflow tract obstruction (DLVOTO). Myocardial function has been reported to be lower in
Takahiro Saito, Takahiro Saito, Ryohei Suzuki, Yunosuke Yuchi, Yunosuke Yuchi, Haru Fukuoka, Shuji Satomi, Shuji Satomi, Takahiro Teshima, Hirotaka Matsumoto   +9 more
doaj   +2 more sources

Optimization and Validation of an HPLC Method for the Analysis of Carvedilol and Impurities. [PDF]

ACS Omega
Yuan L, Liu W, Zhang S, Huang L, Cheng J, He L, Zhao H, Yu Y.   +7 more
europepmc   +3 more sources

A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose

Research in Pharmaceutical Sciences, 2022
Background and purpose: The study was aimed at validating a simple, rapid, and low-cost LC-MS/MS method for carvedilol and 4/-hydroxyphenyl carvedilol assay in human plasma. The validated method was applied to investigate the pharmacokinetics after a low
Wanna Eiamart, Nantaporn Prompila, Yaowatree Jumroen, Nonlanee Sayankuldilok, Pajaree Chariyavilaskul, Supeecha Wittayalertpanya   +5 more
doaj   +1 more source

Effect of Carvedilol on Survival in Severe Chronic Heart Failure [PDF]

New England Journal of Medicine, 2001
Milton Packer, Michal Tendera, David L Demets   +2 more
exaly   +2 more sources

Comparative Study of Selected Excipients’ Influence on Carvedilol Release from Hypromellose Matrix Tablets

Pharmaceutics, 2023
Solid dosage forms based on hypromellose (HPMC) with prolonged/extended drug release are very important from the research and industrial viewpoint. In the present research, the influence of selected excipients on carvedilol release performance from HPMC ...
Tadej Ojsteršek, Grega Hudovornik, Franc Vrečer   +2 more
doaj   +1 more source

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist [PDF]

, 2013
Nebivolol, a third generation β-adrenoceptor (β-AR) antagonist (β-blocker), causes vasodilation by inducing nitric oxide (NO) production. The mechanism via which nebivolol induces NO production remains unknown, resulting in the genesis of much of the ...
Andresen, Bradley T., Bastepe, Murat, Blessing, Christopher P., Erickson, Catherine E., Gul, Rukhsana, Holowka, David, Jackson, Edwin K., Liu, Tammy, Nguyen, Jenny, Pulakat, Lakshmi   +9 more
core   +11 more sources

Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect

Journal of Nanobiotechnology, 2021
Background Carvedilol, the anti-hypertensive drug, has poor bioavailability when administered orally. Ethosomes-mediated transdermal delivery is considered a potential route of administration to increase the bioavailability of carvedilol.
Padmanabha Rao Amarachinta, Garima Sharma, Noufel Samed, Ananda Kumar Chettupalli, Madhusudhan Alle, Jin-Chul Kim   +5 more
doaj   +1 more source